Sigma Healthcare stock heads toward its October AGM at AUD 2.62

Published on 10/08/2026 at 07:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sigma Healthcare stock posted FY2026 revenue of AUD 10.8 billion, up 81 percent from FY2025. Its October 21 AGM gives investors a dated governance checkpoint.

Sigma, AU000000SIG5, Illustration mit AI erstellt.

Sigma Healthcare stock was trading at AUD 2.62 on the ASX on October 8, 2026, down 0.95 percent from the prior close of AUD 2.64. The next dated company checkpoint is the annual general meeting scheduled for October 21, 2026.

AGM sets the next checkpoint

According to FinScry, Sigma Healthcare is scheduled to hold its annual general meeting on October 21, 2026. The meeting gives shareholders a defined date to assess board matters, executive pay and the integration priorities attached to the companys expanded pharmacy platform.

Sigma Healthcare operates pharmaceutical wholesale and distribution activities across Australia alongside a retail pharmacy network that includes Chemist Warehouse, Amcal and Discount Drug Stores. Its operating scale makes execution and margin conversion more important than revenue growth alone.

Revenue grew while margin fell

According to Simply Wall St, fiscal 2026 revenue reached AUD 10.8 billion, up 81 percent from AUD 6.0 billion in fiscal 2025. Net income rose 34 percent to AUD 709.2 million, while profit margin declined to 6.5 percent from 8.8 percent as expenses increased.

Fiscal 2026 EPS was AUD 0.062, compared with AUD 0.051 in fiscal 2025. The combination points to a business growing rapidly through scale, but with profitability still sensitive to the cost of expansion and integration.

Macquarie target stays above price

As Markets Insider reported on October 5, 2026, Macquarie maintained a Buy rating and an AUD 3.20 price target. The target lies 22.1 percent above the ASX price of AUD 2.62, while Morgan Stanley had maintained a Buy rating with an AUD 3.30 target on September 21, 2026.

The valuation gap leaves the October AGM and future margin performance as the practical markers for the stock. Sigma Healthcare had market capitalization of AUD 30.2 billion on October 8, 2026, with trading volume of 8,068,792 shares.

Stock remains below yearly high

Sigma Healthcare was trading 18.1 percent below its 52-week high of AUD 3.20 and above its 52-week low of AUD 2.47 on October 8, 2026. The stock was last at AUD 2.62 on the ASX at 3:41 p.m. AEDT, giving investors a market level to compare with the AUD 3.20 Macquarie target.